Hypertension, Vol 21, 432-438, Copyright © 1993 by American Heart Association
JP Valentin, LA Sechi, C Qui, M Schambelan and MH Humphreys
Urodilatin is a recently described member of the atrial natriuretic peptide
family, thought possibly to be synthesized in the kidney. To determine if
urodilatin binding sites are present in rat and human kidney, we evaluated
the effect of urodilatin on iodine-125-labeled atrial natriuretic peptide
(ANP) (100 pM) binding to tissue sections using an in situ autoradiographic
technique. 125I-ANP binding occurred primarily in glomeruli and medullary
structures of both rat and human kidney. Increasing concentrations of
urodilatin yielded a monophasic displacement of 125I-ANP binding with an
IC50 of 4.2 nM, a value nearly identical to that achieved with unlabeled
ANP (7.2 nM). In additional experiments, rat glomeruli and inner medullary
collecting duct cells were isolated and incubated in vitro with either ANP
or urodilatin (10(- 11) to 10(-6) M) and cyclic
guanosine-3',5'-monophosphate accumulation measured by radioimmunoassay.
Dose-response curves for the two peptides were superimposable in each
tissue; at 10(-6) M, ANP generated 613 +/- 41 and urodilatin 603 +/- 55
fmol cyclic guanosine monophosphate per 10 minutes per milligram protein in
inner medullary collecting duct cells (p = NS). Thus, urodilatin is as
effective as ANP in displacing 125I- ANP binding to both rat and human
renal tissue and in generating cyclic guanosine monophosphate in renal
target cells in the rat, suggesting that its physiological effects may
occur through the same receptors and signaling pathways that mediate the
actions of ANP.
ARTICLES
Urodilatin binds to and activates renal receptors for atrial natriuretic peptide
Division of Nephrology, San Francisco General Hospital, CA 94110.
This article has been cited by other articles:
![]() |
M. Heringlake, K. Wagner, J. Schumacher, and H. Pagel Urinary excretion of urodilatin is increased during pressure natriuresis in the isolated perfused rat kidney Am J Physiol Renal Physiol, September 1, 1999; 277(3): F347 - F351. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Bestle, N. V. Olsen, P. Christensen, B. V. Jensen, and P. Bie Cardiovascular, endocrine, and renal effects of urodilatin in normal humans Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R684 - R695. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |